ASCLEPIX THERAPEUTICS INC has a total of 11 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), Republic of Korea and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are WILSON D TRAVIS, LABORATORIOS LETI S L UNIPERSONAL and 7 HILLS INTERESTS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Republic of Korea | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Mirando Adam | 8 |
#2 | Popel Aleksander S | 7 |
#3 | Pandey Niranjan | 7 |
#4 | Green Jordan J | 7 |
#5 | Kim Jayoung | 5 |
#6 | Shmueli Ron | 5 |
#7 | Lima E Silva Raquel | 5 |
#8 | Campochiaro Peter A | 4 |
#9 | Pandey Niranjan B | 3 |
#10 | Popel Aleksander | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020198481A1 | Compositions and methods for treating ocular disease | |
WO2019204402A1 | Compositions and methods for treatment of cancer | |
EP3661536A1 | Methods for identifying and preparing pharmaceutical agents for activating tie2 receptor | |
CA3063140A1 | Biodegradable microparticles for sustained delivery of anti-angiogenic peptide |